1. Home
  2. SMG vs MIRM Comparison

SMG vs MIRM Comparison

Compare SMG & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scotts Miracle-Gro Company (The)

SMG

Scotts Miracle-Gro Company (The)

HOLD

Current Price

$69.52

Market Cap

4.1B

Sector

Industrials

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$87.89

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMG
MIRM
Founded
1868
2018
Country
United States
United States
Employees
N/A
355
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
5.4B
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
SMG
MIRM
Price
$69.52
$87.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
13
Target Price
$70.83
$108.92
AVG Volume (30 Days)
760.2K
613.8K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
3.75%
N/A
EPS Growth
504.92
74.59
EPS
N/A
N/A
Revenue
$3,016,500,000.00
$19,138,000.00
Revenue This Year
N/A
$24.90
Revenue Next Year
$2.54
$19.87
P/E Ratio
N/A
N/A
Revenue Growth
6.17
N/A
52 Week Low
$45.61
$36.88
52 Week High
$72.35
$109.28

Technical Indicators

Market Signals
Indicator
SMG
MIRM
Relative Strength Index (RSI) 62.42 33.70
Support Level $56.91 $72.17
Resistance Level $71.16 $107.51
Average True Range (ATR) 1.97 3.81
MACD -0.14 -2.59
Stochastic Oscillator 56.79 1.34

Price Performance

Historical Comparison
SMG
MIRM

About SMG Scotts Miracle-Gro Company (The)

Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: